Title:
化合物
Document Type and Number:
Japanese Patent JP2016522835
Kind Code:
A
Abstract:
本発明は、式（Ｉ）の化合物またはその医薬的に許容される塩（式中、Ｒ１〜Ｒ５は、上記の説明で定義された意味のいずれかを有する）；それらの調製方法、それらを含有する医薬組成物、および細胞増殖性の障害の処置におけるそれらの使用に関する。【選択図】なし
Inventors:
Akhtar, Nadim
Bradbury, Robert Hugh
Butter, david
Curly, Gordon Stewart
De Savi, Christopher
Donald, Craig Samuel
Richard Albert, Norman
Osborne, Matthew
Labeau, Alfred Arthur
Redfern, Heather Marie
Helens Elizabeth, Williams
Yavari, Neda
Bradbury, Robert Hugh
Butter, david
Curly, Gordon Stewart
De Savi, Christopher
Donald, Craig Samuel
Richard Albert, Norman
Osborne, Matthew
Labeau, Alfred Arthur
Redfern, Heather Marie
Helens Elizabeth, Williams
Yavari, Neda
Application Number:
JP2016516235A
Publication Date:
August 04, 2016
Filing Date:
May 27, 2014
Export Citation:
Assignee:
AstraZeneca Activrag
International Classes:
C07D471/04; A61K31/437; A61K45/00; A61K47/10; A61K47/18; A61K47/22; A61K47/38; A61P15/00; A61P35/00
Domestic Patent References:
| JP2012528192A | 2012-11-12 | |||
| JP2007518822A | 2007-07-12 | |||
| JP2007500705A | 2007-01-18 | |||
| JPH11349527A | 1999-12-21 |
Attorney, Agent or Firm:
Shinjiro Ono
Yasushi Kobayashi
Shigeo Takeuchi
Osamu Yamamoto
Takumi Terachi
Yasushi Kobayashi
Shigeo Takeuchi
Osamu Yamamoto
Takumi Terachi